Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis

American Journal of Clinical Nutrition

Volumn 99, Issue 4, 2014, Pages 792-803

  Kasarskis, Edward J ^a,b,e   Mendiondo, Marta S ^c,d   Matthews, Dwight E ^f   Mitsumoto, Hiroshi ^g   Tandan, Rup ^f   Simmons, Zachary ^h   Bromberg, Mark B ⁱ   Kryscio, Richard J ^b,d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e LEXINGTON VA MEDICAL CENTER   (United States)

^f UNIVERSITY OF VERMONT   (United States)

^g Och Spine at New York Presbyterian Hospitals   (United States)

^h PENN STATE COLLEGE OF MEDICINE   (United States)

ⁱ UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BODY COMPOSITION; DOUBLY LABELED WATER TECHNIQUE; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; ENERGY EXPENDITURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RESTING METABOLIC RATE; YOUNG ADULT;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; BODY COMPOSITION; BODY MASS INDEX; DISEASE PROGRESSION; ENERGY METABOLISM; FEMALE; HUMANS; INTERNET; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MOTOR ACTIVITY; NUTRITIONAL REQUIREMENTS; OVERWEIGHT; SEVERITY OF ILLNESS INDEX; THINNESS; VITAL CAPACITY; YOUNG ADULT;

EID: 84896908986     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.113.069997     Document Type: Article

References (49)

1. Brooks BRSM, Belden D, Juhasz-Poscine K, Waclawik A, DePaul R, Dogan S, Maser A, Roelke K, Laird M, Malinowski L, et al. Natural history of amyotrophic lateral sclerosis. In: Brown RHJ, Meininger V, Swash M, eds. Amyotrophic lateral sclerosis. London, United Kingdom: Dunitz, 2000:31-58.
2. Chou SM. Pathology - light microscopy of amyotrophic lateral sclerosis. In: Smith RA, ed. Handbook of amyotrophic lateral sclerosis. New York, NY: Marcel Dekker, 1992:133-81.
3. Tandan R, Bradley WG. Amyotrophic lateral sclerosis: part 1. Clinical features, pathology, and ethical issues in management. Ann Neurol 1985;18:271-80. (Pubitemid 15023099)
4. DePaul R, Abbs JH. Manifestations of ALS in the cranial motor nerves: dynametric, neuropathologic, and speech motor data. Neurol Clin 1987;5:231-50. (Pubitemid 17092705)
5. Robbins J. Swallowing in ALS and motor neuron disorders. Neurol Clin 1987;5:213-29. (Pubitemid 17092704)
6. Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufrere B, Couratier P. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr 2001;74:328-34. (Pubitemid 32802018)
7. Silani V, Kasarskis EJ, Yanagisawa N. Nutritional management in amyotrophic lateral sclerosis: a worldwide perspective. J Neurol 1998;245(suppl 2):S13-9. (Pubitemid 28398399)
8. Langmore SE. Issues in the management of dysphagia. Folia Phoniatr Logop 1999;51(4-5):220-30. (Pubitemid 29364731)
9. Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009;73(15):1218-26.
10. Hillel AD, Miller RM. Management of bulbar symptoms in amyotrophic lateral sclerosis. Adv Exp Med Biol 1987;209:201-21.
11. Kirby DF, DeLegge MH, Fleming CR. American Gastroenterological Association technical review on tube feeding for enteral nutrition. Gastroenterology 1995;108:1282-301.
12. Löser C, Aschl G, Hébuterne X, Mathus-Vliegen EM, Muscaritoli M, Niv Y, Rollins H, Singer P, Skelly RH. ESPEN guidelines on artificial enteral nutrition-percutaneous endoscopic gastrostomy (PEG). Clin Nutr 2005;24:848-61. (Pubitemid 41403642)
13. Luu LCT, Kasarskis EJ, Tandan R. Nutritional treatment: theoretical and practical issues. In: Mitsumoto H, Przedborski S, Gordon PH, eds. Amyotrophic lateral sclerosis. New York, NY: Taylor & Francis, 2006:721-35.
14. Kasarskis EJ, Mendiondo MS, Wells S, Malguizo MS, Thompson M, Healey M, Kryscio RJ; ALS Nutrition/NIPPV Study Group. The ALS Nutrition/NIPPV Study: design, feasibility, and initial results. Amyotroph Lateral Scler 2011;12:17-25.
15. Harris JA, Benedict FG. A biometric study of human basal metabolism. Proc Natl Acad Sci USA 1918;4:370-3.
16. Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr 1990;51:241-7.
17. Owen OE, Holup JL, D'Alessio DA, Craig ES, Polansky M, Smalley KJ, Kavle EC, Bushman MC, Owen LR, Mozzoli MA, et al. A re-appraisal of the caloric requirements of men. Am J Clin Nutr 1987;46:875-85.
18. Owen OE, Kavle E, Owen RS, Polansky M, Caprio S, Mozzoli MA, Kendrick ZV, Bushman MC, Boden G. A reappraisal of caloric requirements in healthy women. Am J Clin Nutr 1986;44:1-19. (Pubitemid 16040118)
19. Kasarskis EJ. What does body mass index measure in amyotrophic lateral sclerosis and why should we care? Muscle Nerve 2011;44:4-5.
20. Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Cauratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurol (Tokyo) 1999;53:1059-63. (Pubitemid 29442123)
21. Heffernan C, Jenkinson C, Holmes T, Feder G, Kupfer R, Leigh PN, McGowan S. Rio A, Sidhu P. Nutritional management in MND/ALS patients: an evidence based review. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5:72-83. (Pubitemid 39545335)
22. Slowie LA, Paige MS, Antel JP. Nutritional considerations in the management of patients with amyotrophic lateral sclerosis (ALS). J Am Diet Assoc 1983;83:44-7. (Pubitemid 13072097)
23. Kasarskis EJ, Berryman S, Vanderleest JG, Schneider AR, McClain CJ. Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr 1996;63:130-7. (Pubitemid 26005737)
24. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (phase III). J Neurol Sci 1999;169:13-21. (Pubitemid 29502501)
25. Rosenbaum M, Ravussin E, Matthews DE, Gilker C, Ferraro R, Heymsfield SB, Hirsch J, Leibel RL. A comparative study of different means of assessing long-term energy expenditure in humans. Am J Physiol 1996;270:R496-504.
26. Wang Z, Heshka S, Gallagher D, Boozer CN, Kotler DP, Heymsfield SB. Resting energy expenditure-fat-free mass relationship: new insights provided by body composition modeling. Am J Physiol Endocrinol Metab 2000;279:E539-45.
27. Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-9.
28. Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/ behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009;73(15):1227-33.
29. Schoeller DA. Measurement of energy expenditure in free-living humans by using doubly labeled water. J Nutr 1988;118:1278-89. (Pubitemid 19004381)
30. Schoeller DA, Racine N, Shriver TC, Matthews DE. Doubly labeled water method in IRMS to measure free living energy expenditure. In: Beauchemin D, Matthews DE, eds. Elemental and isotope ratio mass spectrometry. Oxford, United Kingdom: Elsevier, 2010:962-7.
31. Prentice AM. Stable isotopic methods for measuring energy expenditure: applications of the doubly-labelled-water (2H2(18)O) method in free-living adults. Proc Nutr Soc 1988;47:259-68.
32. Schoeller DA, van Santen E. Measurement of energy expenditure in humans by doubly labeled water method. J Appl Physiol 1982;53:955-9. (Pubitemid 12000791)
33. Racette SB, Schoeller DA, Luke AH, Shay K, Hnilicka J, Kushner RF. Relative dilution spaces of 2H- and 18O-labeled water in humans. Am J Physiol 1994;267:E585-90.
34. 2 production from doubly labeled water in humans. Am J Physiol 1993;264:E912-7.
35. Black AE, Prentice AM, Coward WA. Use of food quotients to predict respiratory quotients for the doubly-labelled water method of measuring energy expenditure. Hum Nutr Clin Nutr 1986;40:381-91. (Pubitemid 16016494)
36. Sorenson EJ, Windbank AJ, Mandrekar JN, Bamlet WR, Appel SH, Armon C, Barkhaus PE, Bosch P, Boylan K, David WS, et al. Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology 2008;71:1770-5.
37. Pandyan AD, Johnson GR, Price CI, Curless RH, Barnes MP, Rodgers H. A review of the properties and limitations of the Ashworth and modified Ashworth scales as measures of spasticity. Clin Rehabil 1999;13:373-83. (Pubitemid 29425632)
38. Bouchard C, Tremblay A, Leblanc C, Lortie G, Savarad R, Theriault G. A method to assess energy expenditure in children and adults. Am J Clin Nutr 1983;37:461-7. (Pubitemid 13086430)
39. Kasarskis E, Kryscio R, Mendiondo M, Manamley N, Moore D. Six questions from the ALSFRS convey the same prognostic significance for survival and the total score. Amyotroph Lateral Scler 2012;13(suppl 1):28-9.
40. Nau KL, Bromberg MB, Forshew DA, Katch VL. Individuals with amyotrophic lateral sclerosis are in caloric balance despite losses in mass. J Neurol Sci 1995;129:47-9.
41. Desport JC, Torny F, Lacoste M, Preux PM, Couratier P. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegener Dis 2005;2(3-4):202-7. (Pubitemid 43827922)
42. Shimizu T, Hayashi H, Tanabe H. Energy metabolism of ALS patients under mechanical ventilation and tube feeding. Rinsho Shinkeigaku 1991;31:255-9.
43. Ichihara N, Namba K, Ishikawa-Takata K, Sekine K, Takase M, Kamada Y, Fujii S. Energy requirement assessed by doubly-labeled water method in patients with advanced amyotrophic lateral sclerosis managed by tracheotomy positive pressure ventilation. Amyotroph Lateral Scler 2012;13:544-9.
44. Ravussin E, Lillioja S, Anderson TE, Christin L, Bogardus C. Determinants of 24-hour energy expenditure in man: methods and results using a respiratory chamber. J Clin Invest 1986;78:1568-78. (Pubitemid 17219520)
45. Worwood AM, Leigh PN. Indicators and prevalence of malnutrition in motor neurone disease. Eur Neurol 1998;40:159-63. (Pubitemid 28466706)
46. Desport JC, Preux PM, Truong CT, Courat L, Vallat JM, Couratier P. Nutritional assessment and survival in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:91-6.
47. Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills A-M. Body mass index, not dyslipidemia, is an independent predictor of survival in ALS. Muscle Nerve 2011;44(1):20-4.
48. Mazzini L, Corra T, Zaccala M, Mora G, Del Piano M, Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol 1995;242:695-8.
49. Bradley WG, Anderson F, Bromberg M, Gutmann L, Harati Y, Ross M, Miller RG; ALS CARE Study Group. Current management of ALS: comparison of the ALS CARE database and the AAN practice parameter. Neurology 2001;57:500-4. (Pubitemid 32757600) Stroke